Venclexta Starting Pack
What it is used for
Acute Myeloid Leukaemia VENCLEXTA, as part of combination therapy, is indicated for the treatment of newly diagnosed adult patients with Acute Myeloid Leukaemia (AML) who are ineligible for intensive chemotherapy. This medicine has provisional approval in Australia for the treatment of newly diagnosed patients with AML who are ineligible for intensive chemotherapy. The decision to approve this indication has been made on the basis of interim data (overall response rate and duration of response). Continued approval of this indication depends on verification and description of benefit in confirmatory trials.,Chronic Lymphocytic Leukaemia VENCLEXTA in combination with rituximab is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (CLL) who have received at least one prior therapy. VENCLEXTA monotherapy is indicated for the treatment of: patients with relapsed or refractory CLL with 17p deletion, or patients with relapsed or refractory CLL for whom there are no other suitable treatment options.
How to take it
This medicine is a pack that contains more than one part.
Part 1: Tablet, film coated
Round, biconvex shaped, pale yellow debossed with v on one side and 10 on the other side.
The way to take this medicine is: Oral. This medicine is taken by mouth.
Part 2: Tablet, film coated
Oblong, biconvex shaped, pale yellow debossed with v on one side and 100 on the other side.
The way to take this medicine is: Oral. This medicine is taken by mouth.
Part 3: Tablet, film coated
Oblong, biconvex shaped, beige debossed with v on one side and 50 on the other side.
The way to take this medicine is: Oral. This medicine is taken by mouth.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
How to take it
This medicine is a pack that contains more than one part.
Part 1: Tablet, film coated
Round, biconvex shaped, pale yellow debossed with v on one side and 10 on the other side.
The way to take this medicine is: Oral. This medicine is taken by mouth.
Part 2: Tablet, film coated
Oblong, biconvex shaped, pale yellow debossed with v on one side and 100 on the other side.
The way to take this medicine is: Oral. This medicine is taken by mouth.
Part 3: Tablet, film coated
Oblong, biconvex shaped, beige debossed with v on one side and 50 on the other side.
The way to take this medicine is: Oral. This medicine is taken by mouth.
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Pregnant or planning a pregnancy?
For the active ingredient venetoclax
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Do I need a prescription?
This medicine is available from a pharmacist and requires a prescription. It is
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on March 1, 2020. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.